Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials. - Wikidata - wikimedia - TriplyDB

Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.

Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.

http://www.wikidata.org/entity/Q53055595

about

Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.Positron emission tomographic scans in lymphoma: convention and controversy.Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.PET/CT adapted therapy in Hodgkin disease: current state of the art and future directions.The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma.When should FDG-PET be used in the modern management of lymphoma?WIDEN: A tool for medical image management in multicenter clinical trials.Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study.Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation.Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation--where do we stand?PET-guided clinical trials in Hodgkin lymphoma: to agree or not to agree, that is the reviewer's question.An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010.The Strategies to Homogenize PET/CT Metrics: The Case of Onco-Haematological Clinical Trials.

P2860

Q33586239-87E92C99-2345-4D90-9A52-396E23425F3E Q33696003-589E4F3E-4488-46BB-AB81-F83E7F73889E Q33952842-361E3258-4622-4AC5-BCB5-9424756AAF78 Q34475763-6FF15A28-AF08-4184-B782-1025D0F2A95D Q34495333-83073E50-FE99-4ED9-80E5-ED1788504CBD Q35143471-96986F60-A542-4744-8199-F31D4A706806 Q36399538-9FDB1F63-7550-4415-91A3-D094F9C0B96A Q37240835-73A9DEAD-BBCC-481F-A82A-46F09E88D69D Q38018865-10330E62-0B07-49A0-B02E-7947F147E6B8 Q38110318-E5AF98FC-D272-481A-98B2-CB5B16726C4A Q38153086-5C9A9C86-5DC3-4487-89E4-F2BA1A10EEFF Q38202946-25AF3433-6377-4188-ADA6-C9FDEBBC2ECE Q38933091-3CAD9530-FA0F-45F4-8CA8-0E65713A5959 Q43250306-ADD339E6-2C76-4D9E-9F99-4F9249A07A03 Q43253516-E4C6A190-C077-4F52-8BBB-AF8DBF6424FB Q48194466-74E69D5D-AF8D-48BE-977C-63AB9D6BABE5 Q51596869-069D6076-D528-455E-8F39-333A43E53D04 Q53164168-544F8400-BDA2-41E2-8730-3A890E0ED966 Q54152231-F3D25808-8049-47D4-AE5C-C50D75E84E3F

P2860

Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.

http://www.wikidata.org/entity/Q53055595

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Development and application of ...... allocation in lymphoma trials.

@en

Development and application of ...... allocation in lymphoma trials.

@nl

type

label

Development and application of ...... allocation in lymphoma trials.

@en

Development and application of ...... allocation in lymphoma trials.

@nl

prefLabel

Development and application of ...... allocation in lymphoma trials.

@en

Development and application of ...... allocation in lymphoma trials.

@nl

P1433

Q53055595-91F828AE-6F39-4899-A4ED-FF932AA38728

P1476

Q53055595-113C4B38-8121-4A95-B900-E8EFEB0EB82B

P2093

Q53055595-0E1B592F-AB23-465A-A95E-028790273B9B

Q53055595-1A80F1E5-2709-436C-ABB0-1302C06CC0A3

Q53055595-1F7EE93F-89D2-4736-8CDF-3C6AE3D42755

Q53055595-2972D297-EB40-4370-BEAE-835F08FD5253

Q53055595-3D14DE28-6752-4D04-969D-0A239F6E68F0

Q53055595-59F9C320-938C-4441-997E-B1B82B6CBE3D

Q53055595-70866BB6-B38B-412E-A182-EB275C7AADFB

Q53055595-89D3851F-05B3-4334-A9D2-509546B660F2

Q53055595-ABB38488-DB97-4891-B824-3811E3F6C05D

Q53055595-BC2D4B17-E363-4D0D-B0A6-1E51E9AED070

P304

Q53055595-D6B29774-3616-4959-A49E-0FF3386FC9CF

P31

Q53055595-0E435AC2-22E2-4063-A1DA-866A1941FD32

P356

Q53055595-DCD59439-1E45-428B-8C98-F2A96670E36C

P407

Q53055595-2902F43A-B96E-45E2-89B8-85613913F5F5

P433

Q53055595-6F540ED6-2DA3-4C28-BFC1-8E3E86808BAD

P478

Q53055595-5165C420-98D9-4E07-BD13-B5E1FA064A0A

P50

Q53055595-797E8164-CAB7-4A2C-ADE5-B549E74A4800

Q53055595-BB556116-0BB7-4C6F-A8DB-65DE8539C8D4

Q53055595-CEF5E449-113A-4211-9D37-382C89028A2D

Q53055595-D2493841-CE18-4C12-AFD9-69D90A009BD5

Q53055595-F894516D-7DF9-4004-B7CC-F68602B9F092

P577

Q53055595-1BBBD933-784B-49B5-A9BF-CDC8EAE2B4E4

P698

Q53055595-0AC6385A-8126-4C7F-B0A9-40F9B890D2F4

P356

JCO.2009.22.4089

P1433

Journal of Clinical Oncology

P1476

Development and application of ...... allocation in lymphoma trials

@en

P2093

Gilles Karcher

http://www.w3.org/2001/XMLSchema#string

Jean Lumbroso

http://www.w3.org/2001/XMLSchema#string

John Raemaekers

http://www.w3.org/2001/XMLSchema#string

Marc André

http://www.w3.org/2001/XMLSchema#string

Michel Meignan

http://www.w3.org/2001/XMLSchema#string

Olivier Mundler

http://www.w3.org/2001/XMLSchema#string

Oumedaly Reman

http://www.w3.org/2001/XMLSchema#string

Pierre Olivier

http://www.w3.org/2001/XMLSchema#string

Romain Ricci

http://www.w3.org/2001/XMLSchema#string

Stéphane Bardet

http://www.w3.org/2001/XMLSchema#string

P304

2739-2741

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.22.4089

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Federico

Massimo Federico

Nicolas Mounier

P577

2009-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19398565

http://www.w3.org/2001/XMLSchema#string